TMDX TransMedics Group Inc

Price (delayed)

$127.99

Market cap

$4.22B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.32

Enterprise value

$4.38B

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need ...

Highlights

The revenue has soared by 149% YoY and by 23% from the previous quarter

TMDX's gross profit has surged by 126% year-on-year and by 20% since the previous quarter

TMDX's equity is down by 17% year-on-year but it is up by 16% since the previous quarter

The gross margin has contracted by 9% YoY and by 2.2% from the previous quarter

Sector: Healthcare

Industry: Medical Devices

Website: http://www.transmedics.com

Peers: OBIO OM

Key stats

What are the main financial stats of TMDX

Market

Shares outstanding

32.94M

Market cap

$4.22B

Enterprise value

$4.38B

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

26.26

Price to sales (P/S)

14.12

EV/EBIT

2,663.31

EV/EBITDA

312.76

EV/Sales

14.76

Earnings

Revenue

$296.92M

EBIT

$1.65M

EBITDA

$14.01M

Free cash flow

-$202.89M

Per share

EPS

-$0.32

Free cash flow per share

-$6.19

Book value per share

$4.87

Revenue per share

$9.06

TBVPS

$21.66

Balance sheet

Total assets

$723.83M

Total liabilities

$564.36M

Debt

$516.22M

Equity

$159.47M

Working capital

$438.08M

Liquidity

Debt to equity

3.24

Current ratio

9.72

Quick ratio

8.61

Net debt/EBITDA

11.82

Margins

EBITDA margin

4.7%

Gross margin

62.4%

Net margin

-3.4%

Operating margin

-4.8%

Efficiency

Return on assets

-1.5%

Return on equity

-7.2%

Return on invested capital

0.2%

Return on capital employed

0.2%

Return on sales

0.6%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

TMDX stock price

How has the TransMedics Group stock price performed over time

Intraday

2.85%

1 week

39%

1 month

69.86%

1 year

75.28%

YTD

62.16%

QTD

73.1%

Financial performance

How have TransMedics Group's revenue and profit performed over time

Revenue

$296.92M

Gross profit

$185.29M

Operating income

-$14.22M

Net income

-$10.2M

Gross margin

62.4%

Net margin

-3.4%

The revenue has soared by 149% YoY and by 23% from the previous quarter

TMDX's gross profit has surged by 126% year-on-year and by 20% since the previous quarter

The company's net margin has surged by 86% YoY and by 67% QoQ

The operating margin has surged by 76% year-on-year and by 60% since the previous quarter

Growth

What is TransMedics Group's growth rate over time

Valuation

What is TransMedics Group stock price valuation

P/E

N/A

P/B

26.26

P/S

14.12

EV/EBIT

2,663.31

EV/EBITDA

312.76

EV/Sales

14.76

TransMedics Group's EPS has surged by 66% YoY and by 58% QoQ

The stock's P/B is 153% more than its 5-year quarterly average of 10.4 and 57% more than its last 4 quarters average of 16.7

TMDX's equity is down by 17% year-on-year but it is up by 16% since the previous quarter

The revenue has soared by 149% YoY and by 23% from the previous quarter

The P/S is 26% lower than the 5-year quarterly average of 19.2 but 23% higher than the last 4 quarters average of 11.5

Efficiency

How efficient is TransMedics Group business performance

TransMedics Group's return on sales has surged by 109% QoQ and by 103% YoY

The ROIC has soared by 107% from the previous quarter and by 101% YoY

The ROA has soared by 87% year-on-year and by 64% since the previous quarter

TransMedics Group's return on equity has surged by 61% YoY and by 57% QoQ

Dividends

What is TMDX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for TMDX.

Financial health

How did TransMedics Group financials performed over time

The total assets is 28% more than the total liabilities

The total assets has soared by 152% YoY and by 2.5% from the previous quarter

The company's current ratio rose by 6% YoY and by 4.5% QoQ

TMDX's equity is down by 17% year-on-year but it is up by 16% since the previous quarter

TMDX's debt to equity is down by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.